References
Kaunitz AM, Rosenfield A. Drugs 45: 857–865, 1993
Depo-Provera® US package insert, Upjohn, 1992
British National Formulary 26: 197, 1993
Ceulaer K, et al. Lancet 2: 229–231-1982
Trussell J, Kost K. Stud Fam Plan 18: 237–283, 1987
Siriwongse T, et al. Contraception 26: 487–493, 1982
Belsey EM. Contraception 38: 181–206, 1988
Kamau RK, et al. E Afr Med J 61: 550–555, 1990
Fahmy K, et al. Contraception 44: 419–430, 1991
Virutamasen P, et al. Int J Gynecol Obstet 24: 291–296, 1986
Fahmy K, et al. Contraception 44: 431–444, 1991
Garza-Flores J, et al. Contraception 44: 61–71, 1991
Oyelola OO. Contraception 47: 445–454, 1993
Cundy T, et al. BMJ 303: 13–16, 1991
Cundy T, et al. BMJ 308: 247–248, 1994
Pardthaisong T. J Biosocial Sci 16: 23–34, 1984
Rights and permissions
About this article
Cite this article
Optimising the use of depot medroxyprogesterone acetate. Drugs Ther. Perspect 3, 9–10 (1994). https://doi.org/10.2165/00042310-199403050-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199403050-00004